Potential use of procalcitonin as biomarker for bacterial sepsis in patients with or without acute kidney injury
Yoshihiko Nakamura(Harvard University), Hiroyasu Ishikura(Fukuoka University), Takeshi Nishida(Osaka Prefectural Medical Center), Daiki Ohta(Fukuoka University), Akira Murai(Fukuoka University), Norihiko Matsumoto(Fukuoka University), Mariko Mizunuma(Fukuoka University), Yasumasa Kawano(Fukuoka University)
Cited by 49
Related Papers
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
|Journal of Infection and Chemotherapy|2012|325
Brain-to-cervical lymph node signaling after stroke
|Nature Communications|2019|123
Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: A multicenter prospective study
|Journal of Infection and Chemotherapy|2013|96
Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and Perspectives
|Journal of Clinical Medicine|2021|91